Last updated on November 2019

A Study of Durvalumab or Tremelimumab Monotherapy or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma


Brief description of study

This is a multicenter, open-label, stratified, randomized study to evaluate the safety, tolerability, antitumor activity, PK, pharmacodynamics, and immunogenicity of durvalumab or tremelimumab monotherapy, or durvalumab in combination with tremelimumab or bevacizumab in advanced hepatocellular carcinoma.

Clinical Study Identifier: NCT02519348

Find a site near you

Start Over

Research Site

Scottsdale, AZ United States
  Connect »

Research Site

San Francisco, CA United States
  Connect »

Research Site

New Haven, CT United States
  Connect »

Research Site

Jacksonville, FL United States
  Connect »

Research Site

Tampa, FL United States
  Connect »

Research Site

Indianapolis, IN United States
  Connect »

Research Site

Boston, MA United States
  Connect »

Research Site

New York, NY United States
  Connect »

Research Site

Durham, NC United States
  Connect »

Research Site

Portland, OR United States
  Connect »

Research Site

Philadelphia, PA United States
  Connect »

Research Site

Nashville, TN United States
  Connect »

Research Site

Dallas, TX United States
  Connect »

Research Site

Seattle, WA United States
  Connect »

Research Site

Changchun, China
  Connect »

Research Site

Guangzhou, China
  Connect »

Research Site

Hong Kong, Hong Kong
  Connect »

Research Site

Sha Tin, Hong Kong
  Connect »

Research Site

Benevento, Italy
  Connect »

Research Site

Osakasayama-shi, Japan
  Connect »

Research Site

Seo-Gu, Korea, Republic of
  Connect »

Research Site

Seoul, Korea, Republic of
  Connect »

Research Site

Bukit Merah, Singapore
  Connect »

Research Site

Singapore, Singapore
  Connect »

Research Site

Barcelona, Spain
  Connect »

Research Site

Kaohsiung City, Taiwan
  Connect »

Research Site

Taoyuan City, Taiwan
  Connect »

Research Site

Stony Brook, NY United States
  Connect »

Research Site

Jung-gu, Korea, Republic of
  Connect »

Research Site

Seongnam-si, Korea, Republic of
  Connect »

Research Site

Putzu City, Taiwan
  Connect »

Research Site

Ann Arbor, MI United States
  Connect »

Research Site

Bunkyo-ku, Japan
  Connect »

Research Site

Goyang-si, Korea, Republic of
  Connect »

Research Site

Rochester, MN United States
  Connect »

Research Site

Seodaemun-gu, Korea, Republic of
  Connect »

Research Site

Phoenix, AZ United States
  Connect »